Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Verdonck

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
The Netherlands Journal of Medicine|May 24, 2007
Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions inducedS van Dorp, E Meijer, N W C J van de Donk, et al.
Bone Marrow Transplantation|August 31, 2002
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemiaM van Agthoven, M T Groot, L F Verdonck, et al.
Bone Marrow Transplantation|January 11, 2005
The importance of identifying a back-up donor for unrelated stem cell transplantationS M van Walraven, M B A Heemskerk, J L W T Lie, et al.
Annals of Hematology|June 1, 1993
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentationM B van't Veer, W L van Putten, L F Verdonck, et al.
Transfusion|November 1, 1989
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood productsY C de Graan-Hentzen, J W Gratama, G C Mudde, et al.
Bone Marrow Transplantation|November 27, 2007
Stem cell-derived cardiomyocytes after bone marrow and heart transplantationR A de Weger, I Verbrugge, A H Bruggink, et al.
Leukemia|August 18, 1999
A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative GroupG J Ossenkoppele, B van der Holt, G E Verhoef, et al.
The New England Journal of Medicine|April 20, 1995
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphomaL F Verdonck, W L van Putten, A Hagenbeek, et al.
Clinical & Developmental Immunology|January 25, 2013
Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipientsA E Greijer, S J Stevens, S A Verkuijlen, et al.
Rheumatology (Oxford, England)|September 29, 1999
The depletion of T cells from haematopoietic stem cell transplantsI C Slaper-Cortenbach, M J Wijngaarden-du Bois, A de Vries-van Rossen, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
The Netherlands Journal of Medicine|May 24, 2007
Single-centre experience with nonmyeloablative allogeneic stem cell transplantation in patients with multiple myeloma: prolonged remissions inducedS van Dorp, E Meijer, N W C J van de Donk, et al.
Bone Marrow Transplantation|August 31, 2002
Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemiaM van Agthoven, M T Groot, L F Verdonck, et al.
Bone Marrow Transplantation|January 11, 2005
The importance of identifying a back-up donor for unrelated stem cell transplantationS M van Walraven, M B A Heemskerk, J L W T Lie, et al.
Annals of Hematology|June 1, 1993
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentationM B van't Veer, W L van Putten, L F Verdonck, et al.
Transfusion|November 1, 1989
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood productsY C de Graan-Hentzen, J W Gratama, G C Mudde, et al.
Bone Marrow Transplantation|November 27, 2007
Stem cell-derived cardiomyocytes after bone marrow and heart transplantationR A de Weger, I Verbrugge, A H Bruggink, et al.
Leukemia|August 18, 1999
A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative GroupG J Ossenkoppele, B van der Holt, G E Verhoef, et al.
The New England Journal of Medicine|April 20, 1995
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphomaL F Verdonck, W L van Putten, A Hagenbeek, et al.
Clinical & Developmental Immunology|January 25, 2013
Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipientsA E Greijer, S J Stevens, S A Verkuijlen, et al.
Rheumatology (Oxford, England)|September 29, 1999
The depletion of T cells from haematopoietic stem cell transplantsI C Slaper-Cortenbach, M J Wijngaarden-du Bois, A de Vries-van Rossen, et al.
Pageof 13